Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31091374

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 May 16
First author
André F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2019 Aug;16(8):466. doi: 10.1038/s41571-019-0234-0.
    note
    Source null
    related pmid
    31127192
    relationship
    Comment in
  2. citation
    N Engl J Med. 2019 Aug 15;381(7):686. doi: 10.1056/NEJMc1907856.
    note
    Source null
    related pmid
    31412191
    relationship
    Comment in
  3. citation
    N Engl J Med. 2019 Aug 15;381(7):686-687. doi: 10.1056/NEJMc1907856.
    note
    Source null
    related pmid
    31412192
    relationship
    Comment in

Authors and identifiers

  1. name
    André F
    type
    Author
  2. name
    Ciruelos E
    type
    Author
  3. name
    Rubovszky G
    type
    Author
  4. name
    Campone M
    type
    Author
  5. name
    Loibl S
    type
    Author
  6. name
    Rugo HS
    type
    Author
  7. name
    Iwata H
    type
    Author
  8. name
    Conte P
    type
    Author
  9. name
    Mayer IA
    type
    Author
  10. name
    Kaufman B
    type
    Author
  11. name
    Yamashita T
    type
    Author
  12. name
    Lu YS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    André F
    type
    Author
  2. name
    Ciruelos E
    type
    Author
  3. name
    Rubovszky G
    type
    Author
  4. name
    Campone M
    type
    Author
  5. name
    Loibl S
    type
    Author
  6. name
    Rugo HS
    type
    Author
  7. name
    Iwata H
    type
    Author
  8. name
    Conte P
    type
    Author
  9. name
    Mayer IA
    type
    Author
  10. name
    Kaufman B
    type
    Author
  11. name
    Yamashita T
    type
    Author
  12. name
    Lu YS
    type
    Author
bibliography ids
  1. nci-bib-1aff78ab2bcc6275fda346a1
book metadata
content sha256
3edf9f47183a7712eba18fadda45dfa9c12fd3e31e09aa9933fe6066266f0618
document type
citation
dois
  1. 10.1056/NEJMoa1813904
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:31091374
immutable id
pubmed:31091374@3edf9f47183a7712eba18fadda45dfa9c12fd3e31e09aa9933fe6066266f0618
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
20
name
The New England journal of medicine
nlm unique id
0255562
pages
1929-1940
volume
380
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2019 Aug;16(8):466. doi: 10.1038/s41571-019-0234-0.
    note
    Source null
    related pmid
    31127192
    relationship
    Comment in
  2. citation
    N Engl J Med. 2019 Aug 15;381(7):686. doi: 10.1056/NEJMc1907856.
    note
    Source null
    related pmid
    31412191
    relationship
    Comment in
  3. citation
    N Engl J Med. 2019 Aug 15;381(7):686-687. doi: 10.1056/NEJMc1907856.
    note
    Source null
    related pmid
    31412192
    relationship
    Comment in
outcomes validated
false
pmid
31091374
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
4d4b60f5019f61cf53254172df8c38a479565ef3a2a2ea5730dc9ce2e0d193a7
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 May 16
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31091374/
title
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.

Preserved source evidence · Not medical advice